A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes

NCT06924320 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity and Obesity-related Medical Conditions

Interventions

DRUG: MET233 and MET097
DRUG: Placebo
DRUG: MET233

Sponsor

Metsera, a wholly owned subsidiary of Pfizer